News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
BLA Accepted in China for Boan Biotech’s Denosumab Injection (BA1102) for the Oncology In...
2023-03-21
MORE>
Patient Enrollment Completed for BA9101 Phase 3 Clinical Study
2023-03-14
MORE>
Luye Pharma Receives Clinical Trial Approval in Europe for Its Innovative Formulation Pali...
2023-02-24
MORE>
FDA Approves Luye Pharma’s Rykindo® for the Treatment of Schizophrenia and Bipolar 1 Diso...
2023-01-16
MORE>
Luye Pharma’s Innovative Anti-Cancer Therapy Lurbinectedin to Benefit “Named Patients” ...
2023-01-09
MORE>
Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Tri...
2023-01-09
MORE>
Total:
134
/ Page:
23
First
Prev
5
6
7
8
9
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP